We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Preoperative Prostate MRI Findings Predict Prostate Cancer Recurrence at Rates Similar to Pathology

By MedImaging International staff writers
Posted on 19 Jul 2023
Print article
Image: MRI could have a greater role in risk assessments of prostate cancer in the future (Photo courtesy of Freepik)
Image: MRI could have a greater role in risk assessments of prostate cancer in the future (Photo courtesy of Freepik)

Most clinical models currently used to predict biochemical recurrence (BCR) after radical prostatectomy (RP) rely on staging information from RP specimens, leaving a gap in pre-operative risk evaluation. Now, a new study has found that preoperative prostate MRI exams could offer additional value in predicting BCR of prostate cancer, often showing similar performance to post-surgical pathologic staging.

In the study, researchers at the National Cancer Institute (NCI, Bethesda, MD, USA) investigated the comparative utility of pre-surgical MRI staging information and post-surgical RP pathology staging information in predicting cancer recurrence. The study encompassed 604 prostate cancer patients who underwent both preoperative MRI and postoperative pathology. A genitourinary radiologist retrospectively analyzed the cases of patients who had undergone prostate MRI prior to RP between June 2007 and December 2018. The analysis specifically focused on extraprostatic extension (EPE) and seminal vesicle invasion (SVI) findings from the exams, which were then compared with outcomes to comprehend their potential relation to BCR.

The study found that BCR-free survival rates were similar using each staging method, suggesting a potential improvement in preoperative assessments for prostate cancer patients. When compared with the patients' postoperative pathology results, the detection and/or lack of both EPE and SVI on imaging offered comparable value in predicting cancer recurrence, with just a few percentage points difference in multiple metrics. Currently, BCR prediction predominantly depends on postoperative RP specimen results. However, given the similar accuracy between pathology results and preoperative imaging, MRI could play a more significant role in future risk assessments, according to the researchers.

“MRI staging can preoperatively identify patients at high BCR risk, helping to inform early clinical decision making,” said corresponding author Baris Turkbey, MD, with the Molecular Imaging Branch of the National Cancer Institute.

Related Links:
NCI

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
FMT Radiographic Suite
AdvantagePlus ML1
New
Ultrasound Table
Vascular with Fowler EA Table
New
Radiation Therapy Treatment Software Application
Elekta ONE

Print article
Radcal

Channels

Ultrasound

view channel
Image: The new FDA-cleared AI-enabled applications have been integrated into the EPIQ CVx and Affiniti CVx ultrasound systems (Photo courtesy of Royal Philips)

Next-Gen AI-Enabled Cardiovascular Ultrasound Platform Speeds Up Analysis

Heart failure is a significant global health challenge, affecting approximately 64 million individuals worldwide. It is associated with high mortality rates and poor quality of life, placing a considerable... Read more

General/Advanced Imaging

view channel
Image: The NeuroLF ultra-compact brain Positron Emission Tomography (PET) scanner (Photo courtesy of Positrigo)

Breakthrough Brain PET System Aids Diagnosis of Neurological Disorders

Alzheimer's disease (AD) is the most prevalent type of dementia, representing approximately 70% of all dementia cases in individuals over 60 years of age. As of 2020, there were more than 55 million people... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Calantic Digital Solutions is an orchestrated suite of AI radiology solutions that aims to transform radiology (Photo courtesy of Bayer)

Bayer and Rad AI Collaborate on Expanding Use of Cutting Edge AI Radiology Operational Solutions

Imaging data constitutes approximately 90% of all medical data, with the volume of such data continuously expanding, thereby significantly increasing the workload for radiologists amid existing resource limitations.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.